1031432-16-2

Upstream product

• 1031432-71-9 5-bromo-2-(3-ethylureido)pyridine-4-carbothioamide 
• 70-11-1 α-bromoacetophenone 
• 1031432-73-1 5-bromo-2-(3-ethylureido)isonicotinamide 
• 882499-87-8 methyl 2-amino-5-bromo-pyridine-4-carboxylate 

Downstream Products

• 1031432-52-6 ethyl 6'-{[(ethylamino)carbonyl]amino}-4'-(4-phenyl-1,3-thiazol-2-yl)-3,3'-bipyridine-5-carboxylate 
• 1186112-31-1 6-(3-ethylureido)-4-(4-phenylthiazol-2-yl)pyridine-3-ylboronic acid 
• 1186110-90-6 1-ethyl-3-(4-(4-phenylthiazol-2-yl)-5-(pyrimidin-5-yl)pyridin-2-yl)urea 
• 1186110-92-8 1-ethyl-3-(6'-fluoro-4-(4-phenylthiazol-2-yl)-3,3'-bipyridin-6-yl)urea 
• 1186110-91-7 1-ethyl-3-(5-(2-methoxypyrimidin-5-yl)-4-(4-phenylthiazol-2-yl)pyridin-2-yl)urea 
• 1031431-32-9 6'-{[(ethylamino)carbonyl]amino}-4'-(4-phenyl-1,3-thiazol-2-yl)-3,3'-bipyridine-5-carboxylic acid 
• 1031431-34-1 6'-{[(ethylamino)carbonyl]amino}-N-methyl-4'-(4-phenyl-1,3-thiazol-2-yl)-3,3'-bipyridine-5-carboxamide 

Relevant academic research and scientific papers

HETEROCYCLIC UREA DERIVATIVES USEFUL FOR TREATMENT OF BACTERIAL INFECTION

Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

HETEROCYCLIC UREA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS

Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

CHEMICAL COMPOUNDS

Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also desc